Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ferric chloride solution strong BPC 1973
1311060F0AAABAB
|
Ferric chloride (Topical cleanser) | Ferric chloride | Skin | No data available |
|
Ferriprox 100mg/ml oral solution
0901030I0BBABAE
|
Ferriprox | Deferiprone | Nutrition and Blood | No data available |
|
Ferriprox 500mg tablets
0901030I0BBAAAA
|
Ferriprox | Deferiprone | Nutrition and Blood | No data available |
|
FerroNorm 125mg/ml oral drops
0901011P0BGAACJ
|
FerroNorm | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous calcium citrate 181.5mg tablets
0901011X0AAAAAA
|
Ferrous calcium citrate | Ferrous calcium citrate | Nutrition and Blood | No data available |
|
Ferrous gluconate 120mg/5ml oral solution
0901011H0AAAIAI
|
Ferrous gluconate | Ferrous gluconate | Nutrition and Blood | No data available |
|
Ferrous gluconate 130mg capsules
0901011H0AAAJAJ
|
Ferrous gluconate | Ferrous gluconate | Nutrition and Blood | No data available |
|
Ferrous gluconate 250mg / Folic acid 4mg MR tablets
0901011R0AAAAAA
|
Higher folic acid content | Higher folic acid content | Nutrition and Blood | No data available |
|
Ferrous gluconate 300mg/5ml oral solution
0901011H0AAAGAG
|
Ferrous gluconate | Ferrous gluconate | Nutrition and Blood | No data available |
|
Ferrous gluconate 45mg/5ml oral solution
0901011H0AAAHAH
|
Ferrous gluconate | Ferrous gluconate | Nutrition and Blood | No data available |
|
Ferrous glycine sulfate 141mg/5ml oral solution
0901011K0AAABAB
|
Ferrous glycine sulfate | Ferrous glycine sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 100mg/5ml oral solution
0901011P0AABDBD
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 10mg/5ml oral solution
0901011P0AACACA
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 116mg/5ml oral solution
0901011P0AABFBF
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 120mg/5ml oral solution
0901011P0AABNBN
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 125mg/5ml oral liquid
0901011P0AABYBY
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 137.5mg/5ml oral solution
0901011P0AACHCH
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 140mg/5ml oral solution
0901011P0AABGBG
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 150mg / Folic acid 500microgram MR capsules
0901011Q0AAAIAI
|
Iron and folic acid | Iron and folic acid | Nutrition and Blood | No data available |
|
Ferrous sulfate 150mg/5ml oral solution
0901011P0AABUBU
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 15mg/5ml oral solution
0901011P0AACDCD
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 160mg / Folic acid 400microgram MR tab
0901011Q0AAALAL
|
Iron and folic acid | Iron and folic acid | Nutrition and Blood | No data available |
|
Ferrous sulfate 160mg modified-release tablets
0901011P0AAALAL
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 160mg/5ml oral solution
0901011P0AACCCC
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
|
Ferrous sulfate 180mg/5ml oral solution
0901011P0AABJBJ
|
Ferrous sulfate | Ferrous sulfate | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.